Sign in
Home
Investigation
Nation
Politics
Entertainment
World
More
Kashmir
Pakistan Diary
OPED
Environment
Photo Gallery
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Subscribe Us
Home
Investigation
Nation
Politics
Entertainment
World
More
Kashmir
Pakistan Diary
OPED
Environment
Photo Gallery
More
Search
Bharat Biotech
World’s first Indian nasal vaccine for Covid-19 from Bharat Biotech launched
thenews21bureau
-
January 26, 2023
Biological E, Bharat Biotech together sitting on stockpile of 250 million COVID vaccine doses
PTI NEWS
-
December 28, 2022
Bharat Biotech’s intranasal COVID-19 vaccine to cost Rs 800 for private markets
PTI NEWS
-
December 27, 2022
DCGI nod to Bharat Biotech’s intranasal Covid vaccine for restricted emergency use
PTI NEWS
-
September 6, 2022
Bharat Biotech expects regulator’s nod for intranasal COVID-19 vaccine in August
PTI NEWS
-
August 2, 2022
Covaxin’s booster dose demonstrates immunity, works against emerging variants: Bharat Biotech
PTI NEWS
-
July 20, 2022
Covaxin safe, well-tolerated in 2-18 years age-group: Bharat Biotech
PTI NEWS
-
June 17, 2022
DCGI grants EUA to Corbevax for those aged 5-12, Covaxin for 6-12 age group
PTI NEWS
-
April 26, 2022
Serum Institute of India to give free Covishield vials to private vaccination centres to compensate for price difference
PTI NEWS
-
April 10, 2022
Serum Institute, Bharat Biotech cut prices of COVID-19 vaccines for private hospitals to Rs 225 per dose after discussions with govt
PTI NEWS
-
April 9, 2022
Bharat Biotech seeks full marketing approval from DCGI for its Covid vaccine Covaxin
PTI NEWS
-
January 13, 2022
Bharat Biotech seeks nod for phase-3 trials of intranasal COVID-19 vaccine as booster dose
PTI NEWS
-
December 20, 2021
Covaxin 77.8% effective against COVID-19: Lancet study
PTI NEWS
-
November 12, 2021
Ideal time for booster dose for COVID vaccine is 6 months after 2nd dose: Bharat Biotech MD
PTI NEWS
-
November 10, 2021
COVID-19: Bharat Biotech’s US partner Ocugen seeks FDA approval for Covaxin for children between 2-18 years of age
PTI NEWS
-
November 6, 2021
1
2
3
4
Page 1 of 4